Jacobs Levy Equity Management
MXCT icon

Jacobs Levy Equity Management’s MaxCyte MXCT Stock Holding History

Jacobs Levy Equity Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Sell
270,265
-505,959
-65% -$504K ﹤0.01% 871
2026
Q1 		$545K Sell
776,224
-252,422
-25% -$236K ﹤0.01% 814
2025
Q4 		$1.59M Buy
+1,028,646
New +$1.64M 0.01% 620
2024
Q1 		– Sell
-251,001
Closed -$1.18M – 1013
2023
Q4 		$1.18M Buy
+251,001
New +$977K 0.01% 687

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Jacobs Levy Equity Management's MXCT Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its MaxCyte (MXCT) stake by 65% in Q2 2026, selling an estimated $504K and leaving 270,265 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #871.

Jacobs Levy Equity Management first reported a position in MXCT in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.59M in Q4 2025. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Jacobs Levy Equity Management held 270,265 shares of MaxCyte worth $332K as of Q2 2026.
  • Jacobs Levy Equity Management sold 505,959 MaxCyte shares in Q2 2026, an estimated $504K.
  • MaxCyte made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #871 holding.
  • Jacobs Levy Equity Management first reported a position in MaxCyte in Q4 2023 and has held it in 4 quarters since.
  • Jacobs Levy Equity Management's MaxCyte position peaked at $1.59M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.